Pollard A, MacDonald N, Dube E, Lamden K, Baxter P, Suggitt D
Hum Vaccin Immunother. 2022; 18(7):2087411.
PMID: 36441135
PMC: 9766481.
DOI: 10.1080/21645515.2022.2087411.
Oladunni F, Oseni S, Martinez-Sobrido L, Chambers T
Viruses. 2021; 13(8).
PMID: 34452521
PMC: 8402878.
DOI: 10.3390/v13081657.
Goncalves G, Paiva R
Einstein (Sao Paulo). 2017; 15(3):369-375.
PMID: 29091160
PMC: 5823056.
DOI: 10.1590/S1679-45082017RB4024.
Calegari L, Dias R, de Oliveira M, Pessoa C, Oliveira A, Oliveira A
J Nanobiotechnology. 2016; 14(1):61.
PMID: 27465605
PMC: 4964006.
DOI: 10.1186/s12951-016-0196-7.
Cashman K, Broderick K, Wilkinson E, Shaia C, Bell T, Shurtleff A
Vaccines (Basel). 2015; 1(3):262-77.
PMID: 26344112
PMC: 4494234.
DOI: 10.3390/vaccines1030262.
Prevention of hepatitis B virus infection: from the past to the future.
Orlando R, Foggia M, Maraolo A, Mascolo S, Palmiero G, Tambaro O
Eur J Clin Microbiol Infect Dis. 2015; 34(6):1059-70.
PMID: 25678010
DOI: 10.1007/s10096-015-2341-x.
DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies.
Han K, Sin J
Clin Exp Vaccine Res. 2013; 2(2):106-14.
PMID: 23858401
PMC: 3710918.
DOI: 10.7774/cevr.2013.2.2.106.
DNA immunization as an efficient strategy for vaccination.
Bolhassani A, Yazdi S
Avicenna J Med Biotechnol. 2013; 1(2):71-88.
PMID: 23407787
PMC: 3558129.
T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.
Yang X, Brunham R
Can J Infect Dis. 2012; 9(2):99-108.
PMID: 22451777
PMC: 3307538.
DOI: 10.1155/1998/395297.
Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.
Arevalo-Herrera M, Solarte Y, Marin C, Santos M, Castellanos J, Beier J
Mem Inst Oswaldo Cruz. 2011; 106 Suppl 1:202-11.
PMID: 21881775
PMC: 4830685.
DOI: 10.1590/s0074-02762011000900025.
Advances in combating fungal diseases: vaccines on the threshold.
Cutler J, Deepe Jr G, Klein B
Nat Rev Microbiol. 2006; 5(1):13-28.
PMID: 17160002
PMC: 2214303.
DOI: 10.1038/nrmicro1537.
Should healthy children be vaccinated against influenza? Comments about this query.
Corbeel L
Eur J Pediatr. 2006; 166(6):629-31.
PMID: 17008996
DOI: 10.1007/s00431-006-0285-y.
Rapid-response vaccines--does DNA offer a solution?.
Forde G
Nat Biotechnol. 2005; 23(9):1059-62.
PMID: 16151391
PMC: 7097425.
DOI: 10.1038/nbt0905-1059.
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.
Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M
J Virol. 2005; 79(13):8480-92.
PMID: 15956591
PMC: 1143718.
DOI: 10.1128/JVI.79.13.8480-8492.2005.
Overview of vaccines and vaccination.
Ada G
Mol Biotechnol. 2005; 29(3):255-72.
PMID: 15767703
PMC: 7091467.
DOI: 10.1385/MB:29:3:255.
DNA vaccines against human immunodeficiency virus type 1 in the past decade.
Giri M, Ugen K, Weiner D
Clin Microbiol Rev. 2004; 17(2):370-89.
PMID: 15084506
PMC: 387404.
DOI: 10.1128/CMR.17.2.370-389.2004.
Progress towards achieving new vaccine and vaccination goals.
Ada G
Intern Med J. 2003; 33(7):297-304.
PMID: 12823675
PMC: 7165918.
DOI: 10.1046/j.1445-5994.2003.00365.x.
[Immunisation: Leaps into the future. Vaccine studies at the start of the 21st century (I)].
Navarro Alonso J
Aten Primaria. 2002; 29(9):569-74.
PMID: 12061990
PMC: 7684222.
DOI: 10.1016/s0212-6567(02)70640-9.
Intracutaneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits.
Hu J, Han R, Cladel N, Pickel M, Christensen N
J Virol. 2002; 76(13):6453-9.
PMID: 12050357
PMC: 136259.
DOI: 10.1128/jvi.76.13.6453-6459.2002.
DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV.
Jin J, Yang J, Liu J, Kong Y, Wang Y, Li G
World J Gastroenterol. 2002; 8(3):505-10.
PMID: 12046080
PMC: 4656431.
DOI: 10.3748/wjg.v8.i3.505.
